Q-omics provides the consensus-scored MIR3137 profile across patient tissues and cancer cell-line models. MIR3137 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in MESO. Additionally, MIR3137 RNA expression shows 8,004 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight MESO, and LSCC as cancer lineages where MIR3137 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.